Cellectar opens manufacturing facility for radiolabeled CLR1404
Cellectar opens manufacturing facility for radiolabeled CLR1404
MADISON, Wisconsin-Cellectar has opened its new $3.3 million radiopharmaceutical research, development, and manufacturing facility and headquarters in Madison. The facility allows Cellectar to manufacture and radiolabel its lead compound CLR1404, a phospholipid ether combined with 131Iodine, in compliance with Good Manufacturing Practices.
Articles in this issue
New tobacco product alert: Camel Snus is on the loose
Blueberry punch not quite a 'knock out' blow
Texas voters listen to Lance
Cellectar opens manufacturing facility for radiolabeled CLR1404
High cost of breast MRI screening appears to be justified
Broccoli Sprouts Extract Might Lower Bladder Cancer Risk
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Recent Videos
Related Content
